000 03548nam a22003735i 4500
001 295288
003 MX-SnUAN
005 20160429155221.0
007 cr nn 008mamaa
008 150903s2010 gw | o |||| 0|eng d
020 _a9783540316114
_99783540316114
024 7 _a10.1007/9783540316114
_2doi
035 _avtls000347822
039 9 _a201509030920
_bVLOAD
_c201405050339
_dVLOAD
_y201402070940
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC254-282
100 1 _aBrun del Re, Renzo.
_eeditor.
_9329584
245 1 0 _aMinimally Invasive Breast Biopsies /
_cedited by Renzo Brun del Re.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2010.
300 _axii, 225 páginas 206 ilustraciones 152 en color
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v173
500 _aSpringer eBooks
505 0 _aDocumentation and Correlation of Senologic Findings -- Comparison of Large-Core Vacuum-Assisted Breast Biopsy and Excision Systems -- Sonographically Guided Vacuum-Assisted Breast Biopsy Using Handheld Mammotome -- The Vacora Biopsy System -- Available Stereotactic Systems for Breast Biopsy -- MRI-Guided Minimally Invasive Breast Procedures -- Ductoscopy of Intraductal Neoplasia of the Breast -- Pathology of Breast Tissue Obtained in Minimally Invasive Biopsy Procedures -- Limitations of Minimally Invasive Breast Biopsy -- Advances in Breast Imaging: A Dilemma or Progress? -- Cost–Benefit Analyses -- Systematic Review and Meta-analysis of Recent Data.
520 _aModern imaging methods have made it possible to detect breast cancer at an earlier stage than in the past. Nevertheless, when screening is performed regularly over a 10-year period, 20% of examined women will present a suspicious finding that subsequently proves to be benign. Accordingly, beyond cancer detection an important goal is the identification of benign lesions in a manner that is reliable, tissue sparing, patient friendly, and cost-effective. More than 70% of breast biopsies can now be performed using minimally invasive procedures that meet these criteria. Against this background, it can be concluded that a mammography screening programme without the possibility of minimally invasive biopsies is neither ethically nor economically justifiable. This book examines in detail the diverse minimally invasive diagnostic techniques that may be employed when imaging yields suspicious findings. These include vacuum-assisted minimally invasive breast biopsy systems (ATEC, EnCor, Intact, Mammotome and Vacora), stereotactic systems, MRI-guided procedures, and ductoscopy. Further chapters are devoted to the pathology of the breast tissue obtained using these procedures, their limitations, the implications of recent advances in breast imaging, and the results of cost-benefit analyses. The closing chapter provides a systematic review and meta-analysis of recent data.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783540314035
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-540-31611-4
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c295288
_d295288